No Longer Accepting Cases
Uterine Cancer Lawsuits
An electronic device used to remove tissue during hysterectomy and other women’s surgeries has been shown to significantly increase the risk of certain types of uterine cancer.
Laparoscopic morcellators are electronic medical devices used during different types of surgeries (primarily hysterectomies and other gynecological procedures). The device’s primary function is to remove tissue by first shredding it, then removing it through a small incision in the abdomen.
Although the medical procedure is appealing to patients because of its minimally invasive nature and its ability to promote rapid recovery, more people are becoming aware of the dangers involved.
Morcellation And Leiomyosarcoma
It has been determined that the morcellation procedure has been used in more than 80,000 gynecological surgeries for treating benign fibroid tumors. The morcellator grinds the fibroid tissues so they can be removed through laparoscopic procedures. From time to time, cancer cells hide inside these fibrous tissues and the morcellation procedure, in effect, “seeds” the uterus with the cancer cells.
“What if I don’t know whether a morcellator was used in my surgery?”
ANSWER: If you developed uterine cancer following a surgical procedure (such as myomectomy/removal of fibroids, hysterectomy, oophorectomy, salpingectomy, nephrectomy, splenectomy, or another pelvic surgery), you will probably not know whether morcellation was used during the operation. Don’t worry. With your permission, our team of legal professionals can easily research your medical records and determine what type of process was used.
Growing Concerns About Morcellation & Cancer
A report aired by ABC World News in 2013 discussed how a robotic power morcellator shreds fibrous tissue during a hysterectomy and other similar surgeries. Lately, the morcellation process has come under considerable criticism with fears that it may actually spread undiagnosed cancer around the uterus and abdominal cavity. The ABC report went on to show how some hospitals have already revised their guidelines and the way patients are informed about the procedure.
FDA Safety Alert
On April 17, 2014, the Food & Drug Administration (FDA) issued a letter outlining the problems associated with morcellation and how it has been shown to “seed” undiagnosed leiomyosarcoma in the uterus, leading to the spread of cancer. In the letter, the FDA stated, “Based on currently available information, the FDA discourages the use of laparoscopic power morcellation during hysterectomy or myomectomy for uterine fibroids.”
Morcellation Uterine Cancer Lawsuits
Pulaski Law Firm, P.L.L.C. is now conducting an investigation of these types of cases and is seeking information from those who have undergone hysterectomies and other gynecological procedures, and afterward have developed uterine cancer. If you or a loved one has experienced such a series of events you should contact Pulaski Law Firm, P.L.L.C. right away at 1-800-BAD-DRUG. Our attorneys and legal professionals are ready to answer your questions.